TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Presentation to analysts on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2022